Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)
CAPS Rating:
A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.
A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.
Recs
still promising as ever- eurozone bringin it down makes lots of sense...NOT
http://seekingalpha.com/article/649941-threshold-s-management-presents-at-jefferies-healthcare-conference-notes
was gonna close this one, but more bullish on it than ever now long term